Nutriband Inc (NTRB)
4.73
-0.16
(-3.27%)
USD |
NASDAQ |
Nov 15, 16:00
4.90
+0.17
(+3.59%)
After-Hours: 20:00
Nutriband Research and Development Expense (TTM): 2.863M for July 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| July 31, 2024 | 2.863M |
| April 30, 2024 | 2.534M |
| January 31, 2024 | 1.960M |
| October 31, 2023 | 1.693M |
| July 31, 2023 | 1.432M |
| April 30, 2023 | 1.265M |
| January 31, 2023 | 0.9822M |
| Date | Value |
|---|---|
| October 31, 2022 | 0.9368M |
| July 31, 2022 | 0.8071M |
| April 30, 2022 | 0.5292M |
| January 31, 2022 | 0.4114M |
| October 31, 2021 | 0.161M |
| July 31, 2021 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
Jul 2021
2.863M
Maximum
Jul 2024
1.198M
Average
0.9822M
Median
Jan 2023
Research and Development Expense (TTM) Benchmarks
| NeuroOne Medical Technologies Corp | 5.731M |
| SINTX Technologies Inc | 8.045M |
| enVVeno Medical Corp | 11.72M |
| Beyond Air Inc | 25.68M |
| CVRx Inc | 10.57M |